This online curriculum addresses the management of Metastatic Kidney Cancer and is a mix of live webinars, case discussions, Q&A and discussions by key opinion leaders in kidney cancer. The programme is developed by the European Association of Urology.
Webinar 2: 28 February 2023
1. Recording of Webinar 1
This webinar shows the newest indications for the medical treatment of metastatic renal cell carcinoma (RCC) according to the last evidence showed in literature and the ESMO congress. Lectures will focus on the differential treatment in clear cell versus non-clear cell metastatic RCC and on the importance of prognostic scores to drive treatment in this stage of the disease. The last part of the webinar will focus on how the same agents can be used either as first-line or as second-line treatment in metastatic RCC.
This activity is supported by an educational grant from a pharmaceutical company, with no involvement in the programme or speaker selection.
2. ESOU Online on kidney cancer
In this new ESOU Online programme moderated by Prof. Rouprêt, experts discuss the latest developments in kidney cancer. We have Prof. Bex giving a state-of-the-art lecture on current RCC trials and what’s new in the EAU2022 RCC guidelines, Dr. Kuusk presenting a case on adjuvant treatments and recurrent disease, and finally, Prof. Albiges elaborates on what’s in the pipeline in the field of medical treatment of RCC.
This activity is supported by an educational grant from a pharmaceutical company, with no involvement in the programme or speaker selection.
3. Recent advances in the first-line management of advanced RCC
Industry Session “Recent advances in the first-line management of advanced RCC” at EAU22.
This activity is a promotional session which was hosted by a pharmaceutical company at EAU22.